We are live on
!
Find out more
AstraZeneca
AZN
AZN
1,055 hedge funds and large institutions have $35B invested in AstraZeneca in 2023 Q1 according to their latest regulatory filings, with 87 funds opening new positions, 405 increasing their positions, 348 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
26% more first-time investments, than exits
New positions opened: 87 | Existing positions closed: 69
16% more repeat investments, than reductions
Existing positions increased: 405 | Existing positions reduced: 348
5% more call options, than puts
Call options by funds: $487M | Put options by funds: $466M
0% more capital invested
Capital invested by funds: $34.9B → $35B (+$70.5M)
0.05% less ownership
Funds ownership: 16.44% → 16.39% (-0.05%)
1% less funds holding
Funds holding: 1,061 → 1,055 (-6)
32% less funds holding in top 10
Funds holding in top 10: 19 → 13 (-6)
Holders
1,055
Holders Change
-6
Holders Change %
-0.57%
% of All Funds
16.81%
Holding in Top 10
13
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-31.58%
% of All Funds
0.21%
New
87
Increased
405
Reduced
348
Closed
69
Calls
$487M
Puts
$466M
Net Calls
+$21.3M
Net Calls Change
+$20.1M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$733M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$293M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
+$274M |
| 4 |
Morgan Stanley
New York
|
+$184M |
| 5 |
Goldman Sachs
New York
|
+$103M |
